Billionaire Daniel Sundheim’s Top 15 Stock Picks Heading Into 2025

Page 10 of 14

5. GE Healthcare Technologies Inc. (NASDAQ:GEHC)

D1 Capital Partners’ Equity Stake: $268.16 Million

Number of Hedge Fund Holders as of Q3 2024: 50

GE Healthcare Technologies Inc. (NASDAQ:GEHC) is a healthcare company that develops and manufactures products and services for diagnosing, treating, and monitoring patients. Its Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) and women’s health products.

GE Healthcare Technologies Inc. (NASDAQ:GEHC) delivered solid third-quarter results on October 30, 2024. Its net profit of $470 million, or $1.14 per share on an adjusted basis, easily topped analysts’ estimates of $1.06 per share. Revenue increased 0.9% year-over-year to $4.86 billion, driven by a 6% increase in Pharmaceutical Diagnostics revenue of $625 million.

The future looks bright as GE Healthcare has obtained FDA clearance for GE Healthcare Technologies Inc.’s (NASDAQ:GEHC) SIGNA MAGNUS. The approval should strengthen the company’s neuroimaging unit as it marks a notable advancement in magnetic resonance imaging technology. The medical devices company is also in the process of launching Flyrcado, a new PET imaging agent expected to generate annual revenues of over $500 million.

Additionally, GE Healthcare Technologies Inc. (NASDAQ:GEHC) has made several investments and alliances in the field of artificial intelligence (AI), including a collaboration with Amazon Web Services to create AI medical tools. The company has also unveiled an AI Innovation Lab to accelerate the development of several of its AI initiatives, such as software for detecting breast cancer and AI agents with specialized knowledge in particular care areas.

Page 10 of 14